BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20080592)

  • 21. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.
    Wuyts W; Radersma R; Storm K; Vits L
    Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.
    Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T
    Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.
    Pacifici M
    Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous malformation may be a feature of EXT1-related hereditary multiple exostoses: A report of two unrelated probands.
    Albokhari D; Bailey CR; Hwang F; Weiss CR; Forsberg J; Sobreira N
    Am J Med Genet A; 2023 Jun; 191(6):1570-1575. PubMed ID: 36869625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.
    Stickens D; Brown D; Evans GA
    Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple osteochondromas.
    Bovée JV
    Orphanet J Rare Dis; 2008 Feb; 3():3. PubMed ID: 18271966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
    Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
    J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective chondrocyte proliferation and differentiation in osteochondromas of MHE patients.
    Benoist-Lasselin C; de Margerie E; Gibbs L; Cormier S; Silve C; Nicolas G; LeMerrer M; Mallet JF; Munnich A; Bonaventure J; Zylberberg L; Legeai-Mallet L
    Bone; 2006 Jul; 39(1):17-26. PubMed ID: 16476576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel EXT1 and EXT2 mutations in hereditary multiple exostoses families of Indian origin.
    Vanita V; Sperling K; Sandhu HS; Sandhu PS; Singh JR
    Genet Test Mol Biomarkers; 2009 Feb; 13(1):43-9. PubMed ID: 19309273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [From gene to disease; hereditary multiple exostoses].
    Wuyts W; Bovée JV; Hogendoorn PC
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):162-4. PubMed ID: 11845565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of mutations in EXT1 and EXT2 in Brazilian patients with multiple osteochondromas.
    Santos SCL; Rizzo IMPO; Takata RI; Speck-Martins CE; Brum JM; Sollaci C
    Mol Genet Genomic Med; 2018 May; 6(3):382-392. PubMed ID: 29529714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-phenotype correlation in hereditary multiple exostoses.
    Francannet C; Cohen-Tanugi A; Le Merrer M; Munnich A; Bonaventure J; Legeai-Mallet L
    J Med Genet; 2001 Jul; 38(7):430-4. PubMed ID: 11432960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions.
    Hameetman L; Szuhai K; Yavas A; Knijnenburg J; van Duin M; van Dekken H; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
    J Natl Cancer Inst; 2007 Mar; 99(5):396-406. PubMed ID: 17341731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis.
    Hall CR; Cole WG; Haynes R; Hecht JT
    Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mutation in the EXT-1 gene in an Iranian family affected with hereditary multiple exostoses.
    Foroughmand AM; Galehdari H; Rasouli M; Mohammadian G; Mohammadi M
    Pak J Biol Sci; 2008 Apr; 11(7):1037-41. PubMed ID: 18810975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and functional characterization of the human EXT1 promoter region.
    Jennes I; Zuntini M; Mees K; Palagani A; Pedrini E; De Cock G; Fransen E; Vanden Berghe W; Sangiorgi L; Wuyts W
    Gene; 2012 Jan; 492(1):148-59. PubMed ID: 22037484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational spectrum and clinical signatures in 114 families with hereditary multiple osteochondromas: insights into molecular properties of selected exostosin variants.
    Fusco C; Nardella G; Fischetto R; Copetti M; Petracca A; Annunziata F; Augello B; D'Asdia MC; Petrucci S; Mattina T; Rella A; Cassina M; Bengala M; Biagini T; Causio FA; Caldarini C; Brancati F; De Luca A; Guarnieri V; Micale L; D'Agruma L; Castori M
    Hum Mol Genet; 2019 Jul; 28(13):2133-2142. PubMed ID: 30806661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three novel EXT1 and EXT2 gene mutations in Taiwanese patients with multiple exostoses.
    Chen WC; Chi CH; Chuang CC; Jou IM
    J Formos Med Assoc; 2006 May; 105(5):434-7. PubMed ID: 16638657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas.
    Reijnders CM; Waaijer CJ; Hamilton A; Buddingh EP; Dijkstra SP; Ham J; Bakker E; Szuhai K; Karperien M; Hogendoorn PC; Stringer SE; Bovée JV
    Am J Pathol; 2010 Oct; 177(4):1946-57. PubMed ID: 20813973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb).
    Jennes I; Pedrini E; Zuntini M; Mordenti M; Balkassmi S; Asteggiano CG; Casey B; Bakker B; Sangiorgi L; Wuyts W
    Hum Mutat; 2009 Dec; 30(12):1620-7. PubMed ID: 19810120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.